Omnaris is a steroid nasal spray that is used for treating nasal symptoms caused by seasonal and year-round allergies. By decreasing inflammation, the medication can help reduce runny or stuffy nose, sneezing, and nasal itching. Omnaris, which is available by prescription, is typically used just once a day. Side effects that have been reported with the drug include nosebleeds, headaches, and ear pain.
What Is Omnaris?
Omnaris™ (ciclesonide) is a prescription steroid nasal spray licensed to treat sneezing, runny or stuffy nose, and nasal itching due to allergies (known medically as allergic rhinitis). It can be used to treat both seasonal allergies and allergies that occur all year long (known as perennial allergies).
Allergies occur as the result of the immune system's reaction to normally harmless substances that do not bother most people. This immune system reaction is known as inflammation and involves several different types of cells and several different chemicals in the body.
Omnaris is a corticosteroid, or simply "steroid" for short. Steroids can have many different effects in the body, including anti-inflammatory effects. They decrease inflammation by limiting the body's ability to produce an immune system reaction. Steroids can be effective for treating conditions such as allergies. However, long-term use can cause bothersome and sometimes serious side effects, and this limits the usefulness of many steroids. Because Omnaris is a nasal spray, its effects are generally limited to the nose. This helps prevent many of the long-term side effects.
Although Omnaris is a steroid, it is not the same type of steroid used to enhance athletic performance or to increase muscle mass. These steroids are completely different from the type used in nasal sprays such as Omnaris.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Omnaris [package insert]. Florham Park, NJ: Nycomed US, Inc.;2007 November.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed November 28, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click